Tianmao Group faces delisting risk amid delayed financial reports
Tianmao Group [SZSE:000627] is facing potential delisting risks as it has failed to disclose its 2024 annual report by the July 1st deadline. Trading in Tianmao Group shares has been suspended since May 6, 2025, as the company could not release its annual reports by the April 30 deadline. If the company fails to release the report within two months of this suspension, the Shenzhen Stock Exchange will implement a delisting risk warning. The company cites the need for further verification and refinement of information as the reason for the delay. The company has also received notice from the China Securities Regulatory Commission regarding alleged failure to disclose periodic reports on schedule.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Hubei Biocause Pharmaceutical publishes news
Free account required • Unsubscribe anytime